Cargando…

Autism Spectrum Disorder: Why Do We Know So Little?

Detalles Bibliográficos
Autores principales:	Emberti Gialloreti, Leonardo, Curatolo, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107753/ https://www.ncbi.nlm.nih.gov/pubmed/30174643 http://dx.doi.org/10.3389/fneur.2018.00670

Ejemplares similares

Clustering Analysis Supports the Detection of Biological Processes Related to Autism Spectrum Disorder
por: Emberti Gialloreti, Leonardo, et al.
Publicado: (2020)

Can biological components predict short-term evolution in Autism Spectrum Disorders? A proof-of-concept study
por: Emberti Gialloreti, Leonardo, et al.
Publicado: (2016)

Sex Differences in Autism Spectrum Disorder: Repetitive Behaviors and Adaptive Functioning
por: Siracusano, Martina, et al.
Publicado: (2021)

Population Mental Health and COVID-19: Why Do We Know So Little?
por: Patten, Scott B., et al.
Publicado: (2021)

Using Machine Learning to Explore Shared Genetic Pathways and Possible Endophenotypes in Autism Spectrum Disorder
por: Di Giovanni, Daniele, et al.
Publicado: (2023)

The Impact of COVID-19 on the Adaptive Functioning, Behavioral Problems, and Repetitive Behaviors of Italian Children with Autism Spectrum Disorder: An Observational Study
por: Siracusano, Martina, et al.
Publicado: (2021)

Cortico-Cerebellar Connectivity in Autism Spectrum Disorder: What Do We Know So Far?
por: Crippa, Alessandro, et al.
Publicado: (2016)

Why Has Deep Brain Stimulation Had So Little Impact in Psychiatry?
por: Mocking, Roel J. T., et al.
Publicado: (2021)

Neurodevelopmental Disorders and Adaptive Functions: A Study of Children With Autism Spectrum Disorders (ASD) and/or Attention Deficit and Hyperactivity Disorder (ADHD)
por: Scandurra, Valeria, et al.
Publicado: (2019)

Pregnancy and antibody-mediated CNS disorders: What do we know and what should we know?
por: Cortese, Rosa, et al.
Publicado: (2022)

How little do we know?
por: Waslekar, Sundeep
Publicado: (2007)

On Neutrophil Extracellular Trap (NET) Removal: What We Know Thus Far and Why So Little
por: Santocki, Michal, et al.
Publicado: (2020)

Cerebellar dysfunction and autism spectrum disorders – what do we know?
por: Pinheiro Ramos, C., et al.
Publicado: (2023)

Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations
por: Emberti Gialloreti, Leonardo, et al.
Publicado: (2019)

Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2022)

COVID-19 and social responsiveness: A comparison between children with Sotos syndrome and autism
por: Siracusano, Martina, et al.
Publicado: (2021)

Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022)

Immune Disorders in Hashimoto's Thyroiditis: What Do We Know So Far?
por: Pyzik, Aleksandra, et al.
Publicado: (2015)

Vitamin D and Temporomandibular Disorders: What Do We Know So Far?
por: Kui, Andreea, et al.
Publicado: (2021)

The Physiology of Bone Pain. How Much Do We Really Know?
por: Nencini, Sara, et al.
Publicado: (2016)

Clinical profile and conversion rate to full psychosis in a prospective cohort study of youth affected by autism spectrum disorder and attenuated psychosis syndrome: A preliminary report
por: Riccioni, Assia, et al.
Publicado: (2022)

Metal wear particles: What we know, what we do not know, and why
por: Billi, Fabrizio, et al.
Publicado: (2009)

Neuroproteomics in Epilepsy: What Do We Know so Far?
por: do Canto, Amanda M., et al.
Publicado: (2021)

Eosinophilic Esophagitis—What Do We Know So Far?
por: Wąsik, Jakub, et al.
Publicado: (2023)

HIV and neoplasms: What do we know so far?
por: de Souza, Thais Faria, et al.
Publicado: (2023)

Fibrocartilaginous dysplasia: What do we know so far?
por: Alshalan, Asma, et al.
Publicado: (2023)

COVID-19 and Parkinson’s Disease: What Do We Know So Far?
por: Artusi, Carlo Alberto, et al.
Publicado: (2021)

Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?
por: Descalço, N., et al.
Publicado: (2021)

Olfaction and COVID: The little we Know and what else we need to know
por: Pinna, Fábio de Rezende, et al.
Publicado: (2020)

Coagulation profile in severe COVID-19 patients: what do we know so far?
por: Savioli, Felicio, et al.
Publicado: (2020)

A Rare, Unreported Cognitive Side Effect of Topiramate: Do We Know It All Yet?
por: Karim, Nurose, et al.
Publicado: (2020)

The effects of huntingtin-lowering: what do we know so far?
por: Kaemmerer, William F, et al.
Publicado: (2019)

COVID-19 and Hematology—What Do We Know So Far?
por: Khandait, Harshwardhan, et al.
Publicado: (2020)

COVID-19 and Myocarditis: What Do We Know So Far?
por: Pirzada, Ashar, et al.
Publicado: (2020)

Electronic Cigarettes and Asthma: What Do We Know So Far?
por: Kotoulas, Serafeim-Chrysovalantis, et al.
Publicado: (2021)

COVID-19 and dizziness: What do we know so far?
por: Mezzalira, Raquel
Publicado: (2022)

Atherosclerosis in HIV Patients: What Do We Know so Far?
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

COVID-19 and the liver: What do we know so far?
por: Nasa, Prashant, et al.
Publicado: (2021)

The cognitive effects of esketamine: what do we know so far?
por: Barbosa, M., et al.
Publicado: (2022)

Lisfranc Sports Injuries: What Do We Know So Far?
por: Maduka, Godsfavour C, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lndiptfmru70r162tcg1qq9crr